News
10-17-2023, 09:44 AM
Clinical stage artificial intelligence (AI) drug discovery company Insilico Medicine ("Insilico") has been invited to present scientific data on its novel anti-cancer assets at three major upcoming cancer conferences -- the European Society for Medical Oncology (ESMO) conference in Madrid Oct. 20-24, 2023; the Society of Immunotherapy of Cancer (SITC) conference Nov. 1-5, 2023 in San Diego; and the San Antonio Breast Cancer Symposium (SABCS) Dec. 5-9, 2023.
More... (https://www.news-medical.net/news/20231016/Insilico-Medicine-to-present-scientific-data-on-novel-anti-cancer-assets-at-major-cancer-conferences.aspx)
More... (https://www.news-medical.net/news/20231016/Insilico-Medicine-to-present-scientific-data-on-novel-anti-cancer-assets-at-major-cancer-conferences.aspx)